These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

614 related items for PubMed ID: 18328844

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries.
    Valgimigli M, Malagutti P, Rodriguez Granillo GA, Tsuchida K, Garcia-Garcia HM, van Mieghem CA, Van der Giessen WJ, De Feyter P, de Jaegere P, Van Domburg RT, Serruys PW.
    Am Heart J; 2006 Nov; 152(5):896-902. PubMed ID: 17070153
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM, Nawarskas JJ, Frishman WH.
    Cardiol Rev; 2006 Nov; 14(3):143-50. PubMed ID: 16628023
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical results of unprotected left main coronary stenting.
    Ben-Dor I, Vaknin-Assa H, Lev E, Brosh D, Fuchs S, Assali A, Kornowski R.
    Isr Med Assoc J; 2009 Mar; 11(3):154-9. PubMed ID: 19544705
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
    Lasala JM, Cox DA, Morris DL, Breall JA, Mahoney PD, Horwitz PA, Shaw D, Hood KL, Mandinov L, Dawkins KD.
    Am J Cardiol; 2009 Jun 15; 103(12):1663-71. PubMed ID: 19539073
    [Abstract] [Full Text] [Related]

  • 29. Impact of bifurcation technique on 2-year clinical outcomes in 773 patients with distal unprotected left main coronary artery stenosis treated with drug-eluting stents.
    Palmerini T, Marzocchi A, Tamburino C, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, Di Pede F, Ramondo A, Inglese L, De Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, Barlocco F, De Servi S.
    Circ Cardiovasc Interv; 2008 Dec 15; 1(3):185-92. PubMed ID: 20031677
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.
    Gil RJ, Vassiliev D, Michałek A, Kern A, Formuszewicz R, Dobrzycki S, Lesiak M, Wójcik J, Kardaszewicz P, Lekston A.
    Kardiol Pol; 2012 Dec 15; 70(1):45-52. PubMed ID: 22267425
    [Abstract] [Full Text] [Related]

  • 32. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
    Gómez-Hospital JA, Gomez-Lara J, Rondan J, Homs S, Lozano Martínez-Luengas I, Ferreiro JL, Roura G, Maristany J, Teruel L, Carro A, Avanzas P, Jara P, Esplugas E, Moris C, Cequier A.
    Rev Esp Cardiol (Engl Ed); 2012 Jun 15; 65(6):530-7. PubMed ID: 22521483
    [Abstract] [Full Text] [Related]

  • 33. SPIRIT IV trial design: a large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease.
    Nikolsky E, Lansky AJ, Sudhir K, Doostzadeh J, Cutlip DE, Piana R, Su X, White R, Simonton CA, Stone GW.
    Am Heart J; 2009 Oct 15; 158(4):520-526.e2. PubMed ID: 19781409
    [Abstract] [Full Text] [Related]

  • 34. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I, Costa RA, Leon MB, Lansky AJ, Lasic Z, Cristea E, Trubelja N, Carlier SG, Mehran R, Dangas GD, Weisz G, Kreps EM, Collins M, Stone GW, Moses JW.
    Am J Cardiol; 2006 May 01; 97(9):1317-21. PubMed ID: 16635603
    [Abstract] [Full Text] [Related]

  • 35. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
    Tsuchida K, Colombo A, Lefèvre T, Oldroyd KG, Guetta V, Guagliumi G, von Scheidt W, Ruzyllo W, Hamm CW, Bressers M, Stoll HP, Wittebols K, Donohoe DJ, Serruys PW.
    Eur Heart J; 2007 Feb 01; 28(4):433-42. PubMed ID: 17267457
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].
    Byrne R, Iijima R, Mehilli J, Pache J, Schulz S, Schömig A, Kastrati A.
    Rev Esp Cardiol; 2008 Nov 01; 61(11):1134-9. PubMed ID: 19000488
    [Abstract] [Full Text] [Related]

  • 37. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up.
    Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, Hong MK, Kim JJ, Park SJ.
    Am J Cardiol; 2006 Aug 01; 98(3):352-6. PubMed ID: 16860022
    [Abstract] [Full Text] [Related]

  • 38. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S, Burzotta F, Trani C, Todaro D, Talarico G, Porto I, Leone AM, Niccoli G, Mazzari MA, Mongiardo R, Schiavoni G, Crea F.
    Minerva Cardioangiol; 2008 Feb 01; 56(1):35-42. PubMed ID: 18432167
    [Abstract] [Full Text] [Related]

  • 39. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.
    Rensing BJ, Vos J, Smits PC, Foley DP, van den Brand MJ, van der Giessen WJ, de Feijter PJ, Serruys PW.
    Eur Heart J; 2001 Nov 01; 22(22):2125-30. PubMed ID: 11686669
    [Abstract] [Full Text] [Related]

  • 40. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D, Di Salvo ME, Capranzano P, Seminara D, Caggegi A, Barrano G, Tamburino C.
    Minerva Cardioangiol; 2009 Feb 01; 57(1):1-6. PubMed ID: 19202514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.